Events in 2022

Chair: Dr Matthew Griffiths
14.00 The benefits of including pathology in multidisciplinary training days for forensic paediatric post mortems Lorraine Marshall, NHS Lothian
14.30 UK NEQAS Tissue EQA Scheme Jane Woods, UK NEQAS Cellular Pathology Technique
15.30 The evolution of EQA through Pathology Modernisation Chantell Hodgson, UK NEQAS Cellular
Pathology Technique

Chair: Tracey De Haro
9.00 Recent advances in
immunocytochemistry for melanoma diagnosis
Dr Guy Orchard, Viapath Analytics - An NHS partnership with SYNLAB
9.30 Cellular Pathology in sub- Saharan developing Africa – to share and learn
Scott Gable, Cardiff and Vale University Health Board
10.30 Advanced Specialist Diploma (ASD) in Histological Dissection
Chris Ward, Institute of Biomedical Science
11.00 The histopathology of COVID-19
Dr Vivek Sekawat, Guy’s and St. Thomas’ NHS Foundation Trust
11.30 Advantages & disadvantages of using CT for post-mortem examination
Dr Angus McGregor, Shrewsbury and Telford Hospital NHS Trust

Chair: Dr Nigel Brown
14.00 The screening and quantification of gabapentin
and pregabalin in post-mortem
samplers using high performance liquid chromatography- high resolution mass spectrometry (HPLC- HRMS)
Samantha Maslin, University Hospitals of Leicester NHS Trust
14.15 Dinitrophenol
– more than an explosive Leanne Boxshill, Northumbria Healthcare NHS Foundation Trust
14.30 Laboratory- based drug adherence testing Dr Alexander Lawson, University
Hospitals Birmingham NHS Foundation Trust 15.00 How low are some people prepared to go?
Hypoglycaemia and murder
Prof. Stephen Morley, University Hospitals of Leicester NHS Trust

Chair: Jamie West
9.00 Reproductive Biochemistry – Biochemistry in pregnancy Clare Jeffray, Newcastle upon Tyne Hospitals NHS Foundation Trust
9.30 Pre-eclampsia markers: Current status in clinical practice
Prof. Tim James, Oxford University Hospitals NHS Foundation Trust
10.30 COVID-19: Clinical Chemistry lessons learned
Dr Catherine Bailey, Aneurin Bevan University Health Board
11.00 COVID-19 antibody testing: A cross-discipline approach
Paula Griffiths and James Murphy, Swansea Bay University Health Board
11.30 Pathology in a pandemic. Establishing pathology provision at the UK’s first NHS Nightingale Hospital
Dr Chris Longster, Homerton University Hospital and Jenny Lake, Leeds Teaching Hospitals NHS Trust
12.45 UK NEQAS Clinical Chemistry: More than a tick-box exercise
Dr Rachel Marrington, UK NEQAS, Clinical Chemistry
12.45 Q&A with the Cellular Pathology Examiners, David Muskett

Andrology
Chair: Gary Collins
14.00 Is that allowed? Breaking the stereotypes of a Healthcare Scientist Stuart Long, University Hospitals Birmingham NHS Foundation Trust
14.30 After the diagnosis – patient options after an unfavourable result Stephanie Brooks, The Hewitt Fertility Centre, Liverpool Women’s Hospital
15.00 Bringing about changes to reduce the number of failed vasectomies
Lesley Walsh, Wrightington, Wigan & Leigh NHS Foundation Trust

Cervical Screening Programme
Chair: Kirstie Rice
9.00 National Invasive Cervical Cancer Audit and Disclosure update Philippa Pearmain, NHS England and NHS Improvement
9.30 Enduring impact of HPV vaccination on infection and disease: 10 years and counting Dr Kate Cuschieri, NHS Lothian
10.30 Next- generation sequencing and applications for HPV testing
Daniel Guerendiain, NHS Lothian
11.00 Ensuring Quality in HPV Testing Lynn Govan, University Hospital Monklands, Airdrie
11.30 Self sampling for cervical screening Dr Hasit Patel, Health Services Laboratories LLP
12.45 Cervical cancer audit and MDT case presentations
Sue Mehew, Royal Infirmary of Edinburgh and Eva Halloran, Guy’s and St Thomas’ NHS Foundation Trust

Chair: Jayne Parkes
Quality
14.00 EQA Governance – The road ahead for the UK
Dr Phillip Monaghan, The Christie Pathology Partnership
14.30 Cytospin case studies
Nicki Lawrence, University Hospitals of North Midlands NHS Trust
15.00 Peritoneal dialysate fluid – testing for peritonitis Aimee Pinnington, Staffordshire University

Chair: Dr Bashir Lwaleed
Haemostasis
9.00 British Society for Haematology Guidelines – platelet function testing
Dr Keith Gomez, Royal Free London NHS Foundation Trust
9.30 British Society for Haematology Guidelines – laboratory assays Peter Baker, Oxford University Hospitals NHS Foundation Trust
Case studies
10.30 Chimeric Antigen Receptor Therapy (CAR-T) for treatment of haematological malignancies
Dr Carlos Gonzalez Arias, Royal Marsden NHS Foundation Trust
11.00
Immunophenotyping Dr Fiona Clark, University Hospitals Birmingham NHS Foundation Trust
11.30 P. knowlesi Carly Batson, University Hospitals of North Midlands NHS Trust

Chair: Chris Scott
14.00 Myasthenia gravis - a patient’s perspective Rashmi Rungta, Myaware UK
14.30 Life after the 467, a tale of Bullous Pemphigoid
Ingrid Thompson, PEMFriends UK
15.00 Patient experience – primary immunodeficiency Clare Brailsford,
PID UK

Chair: Tonya Bacon
9.00 Cryoprotein analysis – A UK NEQAS update Dina Patel, UK
NEQAS Immunology, Sheffield
9.30 Investigating cryoproteins – are we offering the best service possible?
Dr Rachel Wheeler, South West London Pathology
10.30 Assay trouble shooting – case study
Penny Feather, Scunthorpe General Hospital
11.00 Goodpastures case study
Faye Sims, Peterborough City Hospital
11.30 Breaking news in Immunology
Dr Graeme Wild, Sheffield Teaching Hospitals NHS Foundation Trust